Sio Capital Management LLC Has Trimmed Holding in Sanofi Sa (SNY) as Share Price Rose

December 8, 2017 - By Michael Collier

Sio Capital Management Llc decreased its stake in Sanofi Sa (SNY) by 32.84% based on its latest 2017Q2 regulatory filing with the SEC. Sio Capital Management Llc sold 88,800 shares as the company’s stock rose 14.25% with the market. The institutional investor held 181,622 shares of the major pharmaceuticals company at the end of 2017Q2, valued at $8.70 million, down from 270,422 at the end of the previous reported quarter. Sio Capital Management Llc who had been investing in Sanofi Sa for a number of months, seems to be less bullish one the $108.51 billion market cap company. The stock increased 0.28% or $0.12 during the last trading session, reaching $43.29. About 1.18M shares traded. Sanofi (NYSE:SNY) has risen 26.96% since December 8, 2016 and is uptrending. It has outperformed by 10.26% the S&P500.

Analysts await Sanofi (NYSE:SNY) to report earnings on February, 14. They expect $0.69 earnings per share, up 2.99 % or $0.02 from last year’s $0.67 per share. SNY’s profit will be $1.73B for 15.68 P/E if the $0.69 EPS becomes a reality. After $1.00 actual earnings per share reported by Sanofi for the previous quarter, Wall Street now forecasts -31.00 % negative EPS growth.

More recent Sanofi (NYSE:SNY) news were published by: Investorplace.com which released: “Think Sanofi SA (ADR) (SNY) Stock When You Think Big Pharma” on December 09, 2016. Also Investorplace.com published the news titled: “5 Reasons Why Sanofi SA (ADR) (SNY) is a Good Stock to Buy Now” on April 12, 2017. Benzinga.com‘s news article titled: “The Pullback In Sanofi Is A Buying Opportunity, Says Argus” with publication date: September 01, 2017 was also an interesting one.

Sanofi (NYSE:SNY) Ratings Coverage

Among 12 analysts covering Sanofi-aventis Sa (NYSE:SNY), 1 have Buy rating, 1 Sell and 10 Hold. Therefore 8% are positive. Sanofi-aventis Sa had 22 analyst reports since October 15, 2015 according to SRatingsIntel. On Tuesday, September 13 the stock rating was upgraded by BNP Paribas to “Neutral”. Morgan Stanley upgraded the stock to “Overweight” rating in Thursday, October 15 report. The stock of Sanofi (NYSE:SNY) has “Overweight” rating given on Thursday, May 12 by Barclays Capital. The rating was downgraded by HSBC on Tuesday, May 3 to “Hold”. The stock of Sanofi (NYSE:SNY) has “Hold” rating given on Thursday, May 11 by Berenberg. The firm earned “Mkt Perform” rating on Monday, November 9 by Bernstein. The firm has “Sell” rating by JP Morgan given on Friday, March 31. The firm has “Neutral” rating by JP Morgan given on Friday, April 21. The stock of Sanofi (NYSE:SNY) has “Buy” rating given on Thursday, September 8 by Berenberg. On Friday, December 1 the stock rating was downgraded by Morgan Stanley to “Underweight”.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.




Free Email Newsletter

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: